Key Players
Competitive Landscape
Wrinkle smoothing products draw competition from three broad business models. Large consumer beauty groups compete through scale and multi-price skincare portfolios, while prestige and research-led companies compete through treatment claims and ingredient platforms. Digital-led beauty groups add faster product launches and direct consumer access. Competition depends on visible treatment relevance, evidence behind claims and the ability to convert initial trial into repeat use.
Investment has increasingly moved toward treatment science and stronger skincare portfolios. The Estée Lauder Companies announced a collaboration with Serpin Pharma in February 2025 to investigate biotechnology for skin longevity applications. L'Oréal Groupe signed an agreement in June 2025 to acquire a majority stake in Medik8, a premium skincare brand known for retinal-led products. Beiersdorf extended EPICELLINE from Eucerin into NIVEA in August 2025, bringing the ingredient into a broader mass-market skincare position.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| February 2025: The Estée Lauder Companies announced a collaboration with Serpin Pharma. | Consumers increasingly expect anti-aging treatments to be supported by credible skin science rather than cosmetic positioning alone. | Prestige skincare groups are investing in biotechnology and longevity research to build future treatment platforms. | Research-led ingredients can support differentiated wrinkle-care products if they translate into substantiated cosmetic benefits. |
| June 2025: L'Oréal Groupe signed an agreement to acquire a majority stake in Medik8. | Premium skincare buyers are increasing demand for ingredient-led products with recognizable actives and treatment routines. | Large beauty groups are acquiring specialist skincare brands with established digital and professional followings. | Retinal-led and treatment-focused portfolios can expand across premium retail while increasing competition for repeat anti-aging spending. |
| August 2025: Beiersdorf introduced NIVEA Cellular Epigenetics Rejuvenating Serum with EPICELLINE. | Consumers want stronger treatment propositions at prices below prestige-only skincare. | Research platforms developed in dermocosmetics are moving into broader consumer brands. | Science-led mass skincare can widen the addressable audience for visible aging and wrinkle-care routines. |
Shiseido and Amorepacific compete through research-led Asian skincare platforms with established anti-aging products. Unilever and Procter & Gamble bring broad consumer reach, while Coty maintains treatment-led skincare brands including Lancaster and philosophy. Kao Corporation participates through sensitive and dermocosmetic skincare platforms. e.l.f. Beauty adds digital distribution and a larger skincare position through rhode and its existing skincare brands.
Source: Future Market Insights, Wrinkle Smoothing Patches Market Report, 2026-2036.
Together the ten market-facing companies cover mass skincare, prestige treatment products and digitally led beauty. Their direct exposure to wrinkle smoothing varies by brand and product family, so the company set should not be interpreted as a ranking of dedicated patch manufacturers.
Who leads the wrinkle smoothing patches market?
Public filings do not disclose a comparable company-share ranking for this narrow category, so no verified corporate leader is assigned. L'Oréal Groupe, Beiersdorf, Shiseido and The Estée Lauder Companies have substantial treatment-led skincare positions, while Procter & Gamble and Unilever bring broader consumer distribution. e.l.f. Beauty has increased its skincare exposure through acquisitions and digital-first brands.
Which suppliers have documented wrinkle-treatment or anti-aging credentials?
Shiseido documents a regulated wrinkle-improvement position in Japan through ELIXIR Retino Power Wrinkle Cream using pure retinol. Beiersdorf supports its anti-aging portfolio through research around EPICELLINE under Eucerin and NIVEA. Amorepacific positions Sulwhasoo's Concentrated Ginseng Rejuvenating line around anti-aging skincare. L'Oréal Groupe expanded its treatment-led portfolio through its agreement to acquire Medik8. These credentials apply to the stated brands and products and should not be generalized across each company's entire skincare portfolio.
Which companies provide wrinkle and age-related skincare products?
Shiseido, Beiersdorf, Amorepacific, L'Oréal Groupe and The Estée Lauder Companies have documented treatment or research platforms relevant to visible aging concerns. Procter & Gamble addresses the category through Olay, while Unilever participates through skincare brands including Pond's. Coty's Lancaster portfolio includes photo-aging and repair positioning. Product scope differs substantially across these companies, so buyers should compare the individual treatment line rather than infer a common wrinkle-smoothing specification.
Which suppliers serve North America and Europe?
L'Oréal Groupe, The Estée Lauder Companies, Beiersdorf, Unilever, Procter & Gamble and Coty maintain established skincare distribution across North America and Europe. e.l.f. Beauty has also expanded across both regions, including through rhode's planned Sephora distribution. Shiseido, Kao Corporation and Amorepacific combine strong Asian positions with international skincare operations. Actual product availability varies by brand, market and regulatory status.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Unilever | Large consumer beauty group with mass and treatment-led skincare brands across multiple price points. | Unilever continued to develop age-related skincare through brands such as Pond's, including Age Miracle, while expanding premium skincare innovation across its Beauty & Wellbeing portfolio. |
| The Estée Lauder Companies | Prestige beauty group investing in longevity research and treatment-led skincare science. | The company announced a collaboration with Serpin Pharma in February 2025 to explore anti-inflammatory biotechnology for cosmetic skincare and skin longevity applications. |
| L'Oréal Groupe | Global beauty group spanning mass, dermocosmetic and premium treatment-led skincare. | L'Oréal signed an agreement in June 2025 to acquire a majority stake in Medik8, an ingredient-led premium skincare company known for Crystal Retinal. |
| Coty | Beauty group with Lancaster, philosophy and Orveda providing its principal skincare exposure. | Coty reported continued investment in skincare during 2025, including the launch of Lancaster Golden Lift and further development of the brand's photo-aging prevention and repair position. |
| Shiseido | Research-led skincare company with established wrinkle-treatment products and regulated efficacy positioning in Japan. | Shiseido announced the renewed ELIXIR Retino Power Wrinkle Cream in August 2025 for a September 21 launch using pure retinol as an approved wrinkle-improvement active in Japan. |
| Kao Corporation | Japanese consumer and beauty group with sensitive-skin and dermocosmetic skincare platforms. | Kao announced the June 2026 expansion of Curél into the Netherlands through Etos Derma as part of its wider EMEA skincare growth strategy. |
| Procter & Gamble | Consumer skincare group with Olay spanning mass anti-aging and treatment-oriented facial care. | Olay marked the twentieth anniversary of Regenerist in 2025 with updated formulations and ingredients, extending one of P&G's established age-related skincare platforms. |
| Amorepacific | Korean beauty group with premium anti-aging and treatment-led skincare brands. | Amorepacific renewed Sulwhasoo's Concentrated Ginseng Rejuvenating line in August 2024, extending the brand's anti-aging platform around ginseng-based skincare research. |
| e.l.f. Beauty, Inc. | Digitally led beauty group expanding from accessible cosmetics into a broader skincare portfolio. | e.l.f. Beauty signed an agreement in May 2025 to acquire rhode, adding a fast-growing skincare brand with direct-to-consumer distribution and planned Sephora expansion in North America and the UK. |
| Beiersdorf | Global skincare group combining mass-market NIVEA with research-led dermocosmetic brands including Eucerin. | Beiersdorf introduced NIVEA Cellular Epigenetics Rejuvenating Serum with EPICELLINE in August 2025 after first deploying the ingredient under Eucerin in 2024. |
Research Methodology
The companies mapped here illustrate the competitive structure rather than an exhaustive company-share ranking. Inclusion reflects documented participation in wrinkle treatment, anti-aging skincare or directly adjacent skincare platforms that compete for the same treatment-led consumer spending within the defined market scope. Evidence is assessed at product and brand level using corporate announcements, product documentation and regulatory information where applicable. Broader corporate skincare activity is not treated as evidence that every company sells a dedicated wrinkle-smoothing patch. Market-share estimates remain proprietary FMI assessments for the forecast period.
